Pneumonia News

Pneumonia incidence was high in patients with HF and especially high in those with HF with preserved ejection fraction, according to new data from the PARADIGM-HF and PARAGON-HF trials.

ACP, citing previous data that indicate at least 30% of outpatient antibiotic prescriptions in the U.S. were “unnecessary” and “often continued for too long,” issued best practices for appropriate antibiotic use in several bacterial infections.

In a randomized controlled trial, tedizolid was noninferior to linezolid for day 28 all-cause mortality in the treatment of gram-positive ventilated hospital-acquired bacterial pneumonia and ventilator-associated pneumonia.

Patients with inflammatory rheumatic disease, but especially those with autoimmune conditions, as well as those treated with rituximab, may be at greater risk for severe COVID-19 pneumonia than the general population, according to data.

While most children with multisystem inflammatory syndrome are previously healthy, those hospitalized with severe COVID-19 pneumonia typically have pre-existing conditions, such as diabetes or obesity, according to data.

A 5-day course of antibiotics was just as effective as the standard 10-day course in treating community-associated pneumonia in nonhospitalized children, according to a study published in JAMA Pediatrics.

Primary care patients with a low lymphocyte count “years before” developing pneumonia were at an increased risk for dying, researchers of a retrospective cohort study wrote in the British Journal of General Practice.

Long-term exposure to air pollutants may pose a significant risk to CV and respiratory health in the Medicare-age population, according to a study published in Circulation.

Current smoking appears to increase individual risk for developing symptomatic COVID-19, according to results published in Thorax.

The FDA has accepted Merck’s 15-valent pneumococcal conjugate vaccine for priority review, the company announced.